Why Earnings Season Could Be Great for Adherex Technologies (FENC)Zacks Investment Research • 02/23/23
Fennec Pharmaceuticals Announces PEDMARK® (sodium thiosulfate injection) Receives Orphan Drug Exclusivity from U.S. FDAGlobeNewsWire • 01/31/23
Fennec Pharmaceuticals Announces Updated NCCN Clinical Practice Guidelines Recommend PEDMARK® (sodium thiosulfate injection) to Reduce the Risk of Cisplatin-Induced Hearing Loss in Pediatric PatientsGlobeNewsWire • 01/25/23
Fennec Pharmaceuticals Announces Third Quarter 2022 Financial Results and Provides Business UpdateGlobeNewsWire • 11/11/22
Fennec: Pedmark Approval Can Help Minimize Chemo-Induced Hearing Loss In Pediatric Cancer PatientsSeeking Alpha • 10/24/22
Fennec Pharmaceuticals Announces Commercial Availability of PEDMARK® (sodium thiosulfate injection) in the United StatesGlobeNewsWire • 10/17/22
Fennec Pharmaceuticals Announces Second Closing of $20 Million Investment from PetrichorGlobeNewsWire • 09/26/22
Fennec Pharmaceuticals Announces FDA Approval of PEDMARK® (Sodium Thiosulfate Injection)GlobeNewsWire • 09/21/22
Fennec Pharmaceuticals Announces Second Quarter 2022 Financial Results and Provides Business UpdateGlobeNewsWire • 08/12/22
Has Adherex Technologies (FENC) Outpaced Other Medical Stocks This Year?Zacks Investment Research • 06/23/22
Wall Street Analysts Predict an 80% Upside in Adherex Technologies Inc. (FENC): Here's What You Should KnowZacks Investment Research • 06/03/22
Fennec Pharmaceuticals Announces First Quarter 2022 Financial Results and Provides Business UpdateGlobeNewsWire • 05/12/22
Can Adherex Technologies Inc. (FENC) Climb 92% to Reach the Level Wall Street Analysts Expect?Zacks Investment Research • 05/03/22
Fennec Pharmaceuticals Announces FDA Acceptance for Filing of New Drug Application Resubmission for PEDMARK™GlobeNewsWire • 04/27/22
FENC Final Deadline: Bronstein, Gewirtz & Grossman, LLC Reminds Fennec Pharmaceuticals Inc. Investors of Class Action and Last Few Hours to Contact the FirmBusiness Wire • 04/11/22
FENC FINAL DEADLINE TODAY: ROSEN, A LEADING LAW FIRM, Encourages Fennec Pharmaceuticals Inc. Investors with Losses to Secure Counsel Before Important April 11 Deadline in Securities Class Action - FENCNewsfile Corp • 04/11/22
CLASS ACTION ALERT: The Law Offices of Vincent Wong Remind Fennec Investors of a Lead Plaintiff Deadline of April 11, 2022PRNewsWire • 04/11/22